127 related articles for article (PubMed ID: 8362380)
1. Anticoagulant and antithrombotic action of the factor Xa inhibitor antistasin (ATS).
Hauptmann J; Kaiser B
Thromb Res; 1993 Jul; 71(2):169-74. PubMed ID: 8362380
[No Abstract] [Full Text] [Related]
2. Anticoagulant potential of synthetic and recombinant inhibitors of factor Xa and thrombin in vitro.
Hauptmann J; Kaiser B
Blood Coagul Fibrinolysis; 1993 Aug; 4(4):577-82. PubMed ID: 8218854
[TBL] [Abstract][Full Text] [Related]
3. Anticoagulant effects of the selective factor XA inhibitors tick anticoagulant peptide and antistasin in the APTT assay are determined by the relative rate of prothrombinase inhibition.
Dunwiddie CT; Smith DE; Nutt EM; Vlasuk GP
Thromb Res; 1991 Dec; 64(6):787-94. PubMed ID: 1798970
[No Abstract] [Full Text] [Related]
4. Quantitative comparison of recombinant hirudin's antithrombotic and anticoagulant activities with those of heparin.
Porta R; Pescador R; Mantovani M; Prino G
Thromb Res; 1990 Feb; 57(4):639-43. PubMed ID: 2326777
[No Abstract] [Full Text] [Related]
5. Selective inhibition of factor Xa in the prothrombinase complex by the carboxyl-terminal domain of antistasin.
Mao SS; Przysiecki CT; Krueger JA; Cooper CM; Lewis SD; Joyce J; Lellis C; Garsky VM; Sardana M; Shafer JA
J Biol Chem; 1998 Nov; 273(46):30086-91. PubMed ID: 9804761
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulant efficacy and immunogenicity of the selective factor Xa inhibitor antistasin following subcutaneous administration in the rhesus monkey.
Dunwiddie CT; Nutt EM; Vlasuk GP; Siegl PK; Schaffer LW
Thromb Haemost; 1992 Mar; 67(3):371-6. PubMed ID: 1641828
[TBL] [Abstract][Full Text] [Related]
7. Expression and characterization of the N-terminal half of antistasin, an anticoagulant protein derived from the leech Haementeria officinalis.
Palladino LO; Tung JS; Dunwiddie C; Alves K; Lenny AB; Przysiecki C; Lehman D; Nutt E; Cuca GC; Law SW
Protein Expr Purif; 1991 Feb; 2(1):37-42. PubMed ID: 1821771
[TBL] [Abstract][Full Text] [Related]
8. Antistasin, a leech-derived inhibitor of factor Xa. Kinetic analysis of enzyme inhibition and identification of the reactive site.
Dunwiddie C; Thornberry NA; Bull HG; Sardana M; Friedman PA; Jacobs JW; Simpson E
J Biol Chem; 1989 Oct; 264(28):16694-9. PubMed ID: 2777803
[TBL] [Abstract][Full Text] [Related]
9. Interaction of antistasin-related peptides with factor Xa: identification of a core inhibitory sequence.
Ohta N; Brush M; Jacobs JW
Thromb Haemost; 1994 Dec; 72(6):825-30. PubMed ID: 7740449
[TBL] [Abstract][Full Text] [Related]
10. Purification and characterization of recombinant antistasin: a leech-derived inhibitor of coagulation factor Xa.
Nutt EM; Jain D; Lenny AB; Schaffer L; Siegl PK; Dunwiddie CT
Arch Biochem Biophys; 1991 Feb; 285(1):37-44. PubMed ID: 1990979
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of thrombin generation in plasma by inhibitors of factor Xa.
Prasa D; Svendsen L; Stürzebecher J
Thromb Haemost; 1997 Oct; 78(4):1215-20. PubMed ID: 9364987
[TBL] [Abstract][Full Text] [Related]
12. Comparison of antithrombotic and hemorrhagic effects of edoxaban, a novel factor Xa inhibitor, with unfractionated heparin, dalteparin, lepirudin and warfarin in rats.
Morishima Y; Honda Y; Kamisato C; Shibano T
Thromb Res; 2013 Aug; 132(2):234-9. PubMed ID: 23768448
[TBL] [Abstract][Full Text] [Related]
13. Leech-derived thrombin inhibitors: from structures to mechanisms to clinical applications.
Corral-Rodríguez MA; Macedo-Ribeiro S; Pereira PJ; Fuentes-Prior P
J Med Chem; 2010 May; 53(10):3847-61. PubMed ID: 20155915
[No Abstract] [Full Text] [Related]
14. Non-amidine-containing 1,2-dibenzamidobenzene inhibitors of human factor Xa with potent anticoagulant and antithrombotic activity.
Masters JJ; Franciskovich JB; Tinsley JM; Campbell C; Campbell JB; Craft TJ; Froelich LL; Gifford-Moore DS; Hay LA; Herron DK; Klimkowski VJ; Kurz KD; Metz JT; Ratz AM; Shuman RT; Smith GF; Smith T; Towner RD; Wiley MR; Wilson A; Yee YK
J Med Chem; 2000 Jun; 43(11):2087-92. PubMed ID: 10841787
[No Abstract] [Full Text] [Related]
15. The anticoagulant and antithrombotic properties of hirudins.
Märki WE; Wallis RB
Thromb Haemost; 1990 Nov; 64(3):344-8. PubMed ID: 2096484
[No Abstract] [Full Text] [Related]
16. Design, synthesis and structure-activity relationship of a series of fragment analogues of antistasin (ATS) and ghilantens (GLS).
Danalev DL; Vezenkov LT; Grigorova B
Bioorg Med Chem Lett; 2005 Oct; 15(19):4217-20. PubMed ID: 16084083
[TBL] [Abstract][Full Text] [Related]
17. Direct thrombin inhibitors and factor xa inhibitors can influence the diluted prothrombin time used as the initial screen for lupus anticoagulant.
Olah Z; Szarvas M; Bereczky Z; Kerenyi A; Kappelmayer J; Boda Z
Arch Pathol Lab Med; 2013 Jul; 137(7):967-73. PubMed ID: 23808469
[TBL] [Abstract][Full Text] [Related]
18. Purification and characterization of inhibitors of blood coagulation factor Xa from hematophagous organisms.
Dunwiddie CT; Waxman L; Vlasuk GP; Friedman PA
Methods Enzymol; 1993; 223():291-312. PubMed ID: 8271959
[No Abstract] [Full Text] [Related]
19. The amino acid sequence of antistasin. A potent inhibitor of factor Xa reveals a repeated internal structure.
Nutt E; Gasic T; Rodkey J; Gasic GJ; Jacobs JW; Friedman PA; Simpson E
J Biol Chem; 1988 Jul; 263(21):10162-7. PubMed ID: 3164720
[TBL] [Abstract][Full Text] [Related]
20. Discovery of transition state factor Xa inhibitors as potential anticoagulant agents.
Zhu BY; Huang W; Su T; Marlowe C; Sinha U; Hollenbach S; Scarborough RM
Curr Top Med Chem; 2001 Jun; 1(2):101-19. PubMed ID: 11899247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
